focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,172.00
Bid: 12,168.00
Ask: 12,170.00
Change: -74.00 (-0.60%)
Spread: 2.00 (0.016%)
Open: 12,240.00
High: 12,306.00
Low: 12,132.00
Prev. Close: 12,246.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 rises after BoE's new rescue measures, midcaps stuck in the red

Thu, 19th Mar 2020 10:48

* FTSE bounces after BoE eases again

* Recent sterling slide helps exporters, banks also gain

* Joules, Playtech, Crest Nicholson scrap dividend

* FTSE 100 up 1.4%, FTSE 250 down 1.4%
(Updates with closing prices)

By Sruthi Shankar

March 19 (Reuters) - Britain's top shares ended a volatile
session higher on Thursday after the Bank of England cut
interest rates to a record low and ramped up its bond-buying
programme in a bid to rescue the economy from the coronavirus
crisis.

After wild swings earlier in the day, the blue-chip FTSE 100
rose 1.4%, with big dollar earners such as Diageo
, Royal Dutch Shell and AstraZeneca
providing the biggest boost, even as the pound recovered from a
35-year low.

The central bank cut interest rates to 0.1%, its second
emergency rate cut in just over a week, and promised 200 billion
pounds of additional bond purchases, and at a much faster pace
than normal.

The moves follow similar drastic measures by other central
banks and governments, including a 330 billion-pound stimulus
package from the UK government earlier this week, to inject
liquidity into markets and stem an economic slowdown, which many
fear may have already pushed the global economy into a short
slump.

"We would not be surprised if the BoE's announcement
prepares the ground for more fiscal announcements soon,"
Citigroup's Christian Schulz wrote in a note.

"We expect further programmes to absorb households' income
losses due to the COVID-19 crisis and eventually also stimulus
and debt forgiveness for companies."

The announcement, however, failed to pull midcap stocks out
of their misery. The FTSE Mid 250 index dropped 1.4% for
its eleventh day of losses after Prime Minister Boris Johnson
enforced tougher measures to contain the virus.

"This (stimulus measures) will help at the margin,
particularly the fiscal spend, if they can find a way to get the
money to businesses and individuals," a fund manager at a UK-
based asset manager said.

"For confidence to meaningfully turn more positive, we need
to see the rate of infection slow in Western markets."

Shares in homebuilder Crest Nicholson slumped 30%
after it cancelled payment of its final dividend along with
financial forecasts for 2020.

Fashion retailer Joules Group and gambling software
maker Playtech also announced similar measures.

A leading ventilator manufacturer, Hamilton Medical, told
Reuters that Britain faces a "massive shortage" of the
ventilators that will be needed to treat critically ill patients
suffering from coronavirus.

Luxury brand Burberry Group warned that sales in
the final weeks of March would plunge by around 70% to 80%
compared to last year.

Pub operator Young & Co's Brewery Plc fell 5.2%
after it said that the closure of some or all of its pubs for at
least a short period was "imminent".

Next rose 5.3% after the clothing retailer said it
could sustain a hit from the coronavirus outbreak of more than 1
billion pounds ($1.2 billion) without exceeding its debt and
bank facilities.
(Reporting by Sruthi Shankar and Devik Jain in Bengaluru;
Editing by Bernard Orr, Saumyadeb Chakrabarty, Kirsten Donovan)

More News
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.